Objective. In this study, we aimed to determine the urinary levels of pyridinium cross-links and urinary b-isomerized fragments derived from the C-telopeptide of the a1 chain of type I collagen (b-CTX ) as markers of bone resorption in patients with ankylosing spondylitis (AS), and to study their relationship to markers of disease activity [erythrocyte sedimentation rate ( ESR)] and to disease subsets of this condition.
Ankylosing spondylitis (AS ) is an inflammatory rheumankylosis is progressively induced by specific ossifications or syndesmophytes. atic disease with spine and sacroiliac joint involvement.
Osteoporosis is a complicating feature of this condi-A peripheral disease may also occur. Sacroiliac joint tion [1] and there is some evidence of a certain degree pain and back ache are typical features of AS, and spine of osteopenia in AS: patients with established AS had a higher incidence of vertebral crush fracture [2, 3] ; bone mineral density (BMD) at the spine and the femoral BMD was also observed in early AS patients without evidence of arthritis (swollen joint or joint effusion). Seventeen patients had a short disease duration (defined syndesmophyte formation [5] . The aetiology of this osteoporosis remains controversial: a reduced range of as ∏5 yr). The study group were analysed for sacroiliac joint changes on pelvic X-rays (sacroiliitis) as well as movement of the spine in ankylosing patients, the treatment given or the inflammatory cytokines could contribthe dorsolumbar X-ray features (for the presence of syndesmophytes). The patients were assessed by two ute to this bone loss.
For several years, there has been considerable interest physicians ( ET, DW ) for Schober's test. A clinical index of disease activity (Bath Ankylosing Spondylitis Disease in bone metabolism and its markers in inflammatory rheumatic diseases. Bone remodelling may be evaluated Activity Index; BASDAI ) [16 ] was also evaluated. Laboratory activity was assessed by the Westergren by markers of bone formation and bone resorption. Among these markers, the pyridinium cross-links of erythrocyte sedimentation rate ( ESR) and the C-reactive protein (CRP). Serum calcium, parathormone (PTH ), collagen are useful measures of bone resorption [6, 7] . The pyridinium cross-links include pyridinoline (Pyr) 25 OHD 3 and osteocalcin (OC ) levels were also determined. and deoxypyridinoline (Dpyr). Pyr is a major cross-link found in cartilage and is also present in bone and other
Patients excluded from this study corresponded to post-menopausal women, and patients with a condition tissue, whereas Dpyr is located in bone and dentine [7] [8] [9] [10] . Thus, Dpyr is a more specific cross-link comor a treatment which might alter the bone mineral metabolism: Paget's disease, hyperthyroidism, hyperpound of bone than Pyr and is considered as a marker of type I collagen breakdown. Urinary excretion of these parathyroidism, ongoing corticosteroid therapy, thyroxine and anticonvulsants. collagen components has been used to assess wholebody collagen degradation. More recently, a new urinary Controls marker of degradation of collagen was described, an eight amino acid peptide located in the carboxy-terminal
The control group included 25 healthy volunteers (mean age 35.04 ± 9.5; 15 males and 10 females; no posttelopeptide of the a1 chain of type I collagen or CTX [11] . A b-isomerization of the aspartic residue within menopausal women) without a history of inflammatory rheumatic disease or condition responsible for bone loss. this telopeptide can occur, giving a modified structural peptide or b-CTX [12] . It is thought that this process
The exclusion criteria were the same as for the AS group. reflects the aging of the molecule.
Methods Some studies had demonstrated that these markers were elevated in rheumatic diseases, including rheumaThe serum and urine samples (second void collection) were collected at 8.00 a.m. Fasting venous blood samples toid arthritis (RA) [13] and osteoarthritis [13, 14] . In RA, a correlation between the pyridinium cross-links were taken from each patient and control and the serum stored at −20°C. Serum OC concentration, PTH and and the biochemichal markers of disease activity was generally observed.
25 OHD 3 serum levels were determined using commercial kits (RIA, ost K-PR, Cis-Bio, Gif-sur-Yvette, The aim of this study was to investigate the BMD and the urinary levels of the pyridinium cross-links and France; IRMA, Nichols, CA, USA; RIA, 125I RIA kit, Incstar MN, USA). The intra-and interassay coefficients b-CTX in AS patients, and to examine whether a relationship between these bone markers and disease of variation were: OC, 3.7 and 7%; PTH, 3.4 and 4.5%; 25 OHD 3 , 5.9 and 9.5%. CRP and ESR were determined activity and/or clinical features of AS could be found.
by routine laboratory procedures. The urinary levels of pyridinium cross-links were measured in 2 h fasting urine specimens (second morning Patients and methods samples) and corrected for the creatinine excretion. The Patients methods used were ELISA tests. The urinary combined free pyridinium cross-links, corresponding to the A cross-sectional study was conducted. Thirty-two patients satisfying the modified New York criteria for sum of free pyridinoline and free deoxypiridinoline (f-Pyr + f-Dpyr), were evaluated with the urinary free AS [15] were studied. This group included 23 males and nine females (no post-menopausal patients). The mean deoxypyridinoline (f-Dpyr) (Pyrilinks and Pyrilinks-D, Metra Biosystems, USA, respectively) [17] . The intraage was 36.7 yr (± 13.9) and the mean disease duration was 5.7 yr (± 4.5). Twenty-three patients had the HLAand interassay coefficients of variation were 5.1 and 6.7% for (f-Pyr + f-Dpyr) [17] , and 6.2 and 9.1% for B27 antigen. All the patients took non-steroidal antiinflammatory drugs and 14 had received corticosteroids f-Dpyr [18] . The urinary free pyridinoline levels (f-Pyr) were obtained by difference between (f-Pyr + f-Dpyr) (this was an intermittent administration with a daily dose of <15 mg prednisolone/day, during a maximal and f-Dpyr. The urinary b-isomerized fragments derived from the period of 3 months). However, no steroids were given 3 months prior to the inclusion in this study for all the C-telopeptide of the a1 chain of type I collagen (GluLys-Ala-His-b-Asp-Gly-Gly-Arg or b-CTX ) were measpatients. Twenty patients had exclusive axial disease and 12 peripheral disease. Peripheral disease was defined by ured with the CrossLaps kit (Osteometer, Denmark) [11] . The intra-and interassay coefficients of variation involvement of a peripheral joint such as knee, hip, wrist, elbow, ankle or carpal and metacarpal joints with were 5.3 and 6.6%, respectively [19] .
BMD was measured at the lumbar spine and the ponding T score was also decreased in the AS group (P = 0.03). The femoral neck BMD and T score were femoral neck by dual X-ray absorptiometer (SOPHOS XRA, Sopha Medical, Buc, France). Results were given also found to be decreased in the patient group, but results did not reach the significant level (BMD as BMD and T score which correspond to the number of standard deviations of any result from the peak bone P = 0.08; T score P = 0.11) ( Table 2) . Additionally, lumbar spine and femoral neck BMD did not differ mass-related population mean (the normal ranges were provided by the manufacturers of the bone between AS patients who had had steroids and the AS group who had not [ lumbar spine BMD: AS with densitometer).
previous steroid administration = 0.94 g/cm2 (T score Statistical analysis −1.45) and AS without steroids = 0.95 g/cm2 (T score −1.31) (P = 0.8); femoral neck BDM: AS with previous Results were given as mean ± .. Statistical significance between patients and controls was estimated by steroid administration = 0.75 g/cm2 (T score −1.74) and AS without steroids = 0.82 g/cm2 (T score −1.0) Student's t-test and the Mann-Whitney test was used to compare results in subgroups of AS patients. The cor-(P = 0.12)]. relation between variables was analysed by Spearman's test. Since several parameters could influence the levels Urinary pyridinium cross-links and b-CTX levels of urinary pyridinium cross-links, analysis with stratiNo difference in the urinary pyridinium cross-links and fication of patients was performed and results were given b-CTX levels was observed between AS and controls by the Mantel-Haenszel x2 test. The level of significance ( Table 2 ). was <0.05.
Correlation between markers of disease activity and

Results
urinary pyridinium cross-links
In order to determine whether pyridinium cross-link Details on the clinical and radiological features of the AS group are summarized in Table 1 . In this patient excretion was enhanced in AS patients with active disease, we studied the relationship between these comgroup, 22 had radiological evidence of sacroiliitis, but the 10 patients without X-ray changes in the sacroiliac pounds and markers of disease activity ( ESR, CRP and BASDAI ). A positive correlation was found between joints also satisfied the New York criteria for AS. Dorsolumbar X-ray analysis showed that only six ESR and (f-Pyr + f-Dpyr) (r = 0.42, P = 0.018) and between ESR and f-Dpyr (r = 0.49; P = 0.005) (Fig. 1) . patients had syndesmophytes. The mean Schober's test was 3.3 cm (± 1.1). Finally, 12 patients had AS with
No correlation was found between ESR and lumbar spine BMD or T score (r = − 0.16, P = 0.38 and peripheral involvement at the time of examination. However, neither joint space narrowing nor erosive r = − 0.15, P = 0.42, respectively), and between ESR and femoral neck BMD or T score (r = − 0.30; P = changes were observed on X-rays of the involved peripheral joints.
0.09 and r = − 0.31; P = 0.08, respectively). Finally, there was no correlation between the studied bone Serum markers of bone metabolism and BMD in markers and the CRP serum levels and/or the patients and controls BASDAI score. Furthermore, the levels of urinary bone markers did The levels of the different serum bone markers were in the normal range without difference between AS and not correlate with the age of patients and with lumbar spine BMD (or T score), and there was no correlation controls ( Table 2) .
The lumbar spine BMD was significantly lower in AS between OC and the pyridinium cross-links or b-CTX and between OC and ESR (data not shown). patients compared to controls (P = 0.01). The corres- 32.1 ± 14.9 mm/h) had significantly higher f-Dpyr urinary levels than the other patients (P = 0.009) ( Table 3) . A significantly enhanced (f-Pyr + f-Dpyr), f-Pyr and f-Dpyr excretion was observed in patients with early disease (P = 0.01, 0.02 and 0.01, respectively) ( Table 3) .
Additionally, female AS patients were found to have significantly enhanced f-Dpyr levels compared to male patients (P = 0.01) ( Table 3) .
However, subgroups of AS (peripheral and early diseases, women) included patients with elevated ESR ( Table 3) . In order to determine whether each parameter ( ESR, disease duration, peripheral disease and sex) may influence the bone marker excretion, the patients were stratified according to these variables and the MantelHaenszel x2 test was used. This allowed us to observe that only f-Dpyr urinary levels were significantly elevated in patients with raised ESR, independently from the disease duration, a peripheral involvement and sex (Mantel-Haenszel x2 tests: P = 0.007, P = 0.04 and P = 0.02, respectively). No significant differences were found for the other pyridinium crosslinks and for b-CTX after this stratification. Discussion F. 1. Correlation between urinary combined free pyridinium Our study was undertaken to determine the urinary cross-links, urinary free deoxypyridinoline and ESR. levels of pyridinium cross-links and b-CTX in AS patients. These biochemical markers of bone remodelling Urinary pyridinium cross-links according to clinical are increased in RA and related to markers of disease features of AS activity such as ESR and CRP. A correlation between the enhanced urinary levels of these bone markers and We then examined the urinary cross-link levels in the different disease subsets of AS: axial or peripheral the observed osteoporosis in RA is suggested by several studies [20] [21] [22] . involvement, patients with elevated biochemical markers of disease activity ( ESR > 15 mm/h) and in those with A similar bone loss leading to a generalized osteoporosis is also a complicating feature of AS [1] . Our study early disease (∏5 yr).
The (f-Pyr + f-Dpyr) and f-Dpyr urinary levels were included AS patients with bone loss since this group had significantly lowered BMD and T score at the significantly enhanced in AS patients with peripheral disease when compared to axial disease (P = 0.04 and lumbar spine. These data are consistent with previous studies of BMD assessment in AS [4, 5] . We evaluated 0.04, respectively). For f-Pyr, a tendency of elevated urinary levels was observed in peripheral AS patients, the urinary levels of pyridinium cross-links and b-CTX in our AS patients with evidence of low BMD. We but without significant difference (P = 0.07) ( Table 3) .
Patients with raised ESR (>15 mm/h; mean: found no difference between the AS group and the controls for all the evaluated collagen compounds. This et al. [25] did not study the relationship between laboratory inflammatory markers and the collagen pyridinium is in contradiction with one study of pyridinium crosslinks in AS: Marhoffer et al. [23] evaluated the pyridinocross-links. Similar results are described for pyridinium cross-links in RA [20, 22] , suggesting a role for inflamline compound (the total pyridinoline and not free or another pyridinium cross-link) in AS. This collagen matory markers and acute-phase reactants in the bone loss of these inflammatory conditions. Inflammatory component was found to be significantly increased as compared to controls. More recently, the urinary f-Pyr cytokines probably play a role in this increased excretion of pyridinium cross-links. and f-Dpyr were evaluated in spondylarthropathies: the urinary levels of these pyridinium cross-links were in An apparent contradiction is given by the lack of correlation between lumbar spine BMD and urinary the normal range [24] . A third study found normal levels of urinary cross-links (f-pyr and f-Dpyr) in a series pyridinium cross-links in AS. However, the excretion of these collagen compounds reflects the bone degradation of 19 men with AS [25] .
Controversial results for urinary pyridinium crossat the time of assessment, whereas BMD is an evaluation of the bone mass and thus of bone loss over several years. links in AS and spondylarthropathies are thus observed. This may be explained by differences in stages of disease
We also evaluated in our study the urinary levels of b-CTX, a new marker of type I collagen breakdown [11] . activity, in disease duration, in clinical features and probably in sex. Another explanation is that proteinThis latter was found to be in the normal range and did not correlate with markers of disease activity. Our data bound and/or free cross-links of collagen have been evaluated and therefore different results in the urinary suggest that the different markers of bone resorption (pyridinium cross-links and b-CTX ) are not excreted at excretion of pyridinium may be observed. However, a good correlation between total and free cross-links has the same level in AS. Thus, b-CTX does not seem useful for the evaluation of bone remodelling in this condition. been observed in normal people [24] . In addition, the patients studied by MacDonald et al. [24] corresponded To our knowledge, this marker has not been evaluated in AS and other inflammatory rheumatic diseases. to a non-homogeneous group (spondylarthropathies and not only AS ). In our study, we have measured the Bone formation was also evaluated in our study by serum OC, and no difference was found between AS combined free pyridinium cross-links (f-Pyr + f-Dpyr). Since the f-Pyr levels were obtained by difference and controls. Conflicting results were reported for OC in AS [26, 27] , but no variation in the serum levels of between (f-Pyr + f-Dpyr) and f-Dpyr, there was another possible error in the measurement of f-Pyr which this marker is generally observed in AS [25] . Specific skeletal alkaline phosphatase was found in the normal included the sum of the error for the other two crosslink measurements. range in AS [22, 25] . As suggested by normal serum OC in our study (and results from others), a decreased In our study, a correlation between inflammatory markers of disease activity ( ESR, but not CRP) and rate of bone formation did not distinguish AS. As expected, serum markers of bone metabolism (serum bone resorption markers was found. This was more evident for the urinary combined free pyridinium crosscalcium, PTH, 25 OHD 3 ) were in the normal range in the AS group [26 ] . links and f-Dpyr. These results are consistent with the previous studies of biochemical markers of bone resorpWe have specifically studied the markers of collagen breakdown according to the clinical features of AS. tion in AS and spondylarthropathies [23, 24] . High levels of urinary pyridinoline were observed in AS Firstly, we observed significantly higher urinary levels of f-Dpyr in female AS. This is consistent with previous patients with raised ESR and/or CRP in the group studied by Marhoffer and similar results were found for reports which find a similar difference for this collagen compound between females and males in normal people f-Pyr, f-Dpyr and CRP in a second study [24] . Bronson
